A unique bacterial strain isolated from a patient with pelvic pain could be the key to treating prostate cancer with immunotherapy, according to a study published in Nature Communications.
Along with Deerfield Management, Northwestern has announced a $65 million investment and the launch of Lakeside Discovery, LLC, with the mission to accelerate the translation of transformative biomedical technologies.
Northwestern Medicine investigators are developing better treatments and care for patients with the most prevalent of diseases. Read the feature in Northwestern Medicine magazine.
The presence of cancer cells in the bloodstream of patients with early-stage breast cancer may be predictive of benefit from radiotherapy after surgery, according to a new Northwestern Medicine study.
A Northwestern Medicine study has expanded the understanding of nicotine’s influences on the brain’s reward pathway, with implications for the development of anti-addiction therapies.
A team of scientists has uncovered the precise cells that flow into and harm the lung soon after a transplant. The study, published in The Journal of Clinical Investigation, may lead to drug therapies that target the destructive cells.
A team of scientists has discovered that in children with epilepsy thought to be caused by a spontaneous mutation, about 10 percent of parents in fact carry the same variant in a small proportion of their own cells.
Genetic mutations dysregulating synapse function contribute to a toxic cascade that leads to neurodegeneration in Parkinson’s disease, according to a Northwestern Medicine study.
Northwestern Medicine scientists have discovered an epigenetic imbalance that can lead to cancer, and used these findings to inhibit tumors in models.
Drugs commonly used to prevent HIV transmission from mother to child during pregnancy were not associated with a higher risk of adverse birth outcomes, according to a new study.